Clinical Trial Update: Application of Artificial Intelligence and Iron Metabolism Markers in Predicting ICU Outcomes for Critically Ill Cancer Patients

View source ↗

Summary

A completed clinical trial investigates using artificial intelligence and iron metabolism markers to predict ICU outcomes in critically ill cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Tongji University | Conditions: Cancer | Status: COMPLETED